These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


210 related items for PubMed ID: 30890845

  • 1. Choice of therapeutic anti-seizure medication in patients with brain tumour.
    Laghari AA, Ahmed SI, Qadeer N, Shamim MS.
    J Pak Med Assoc; 2019 Mar; 69(3):442-444. PubMed ID: 30890845
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management.
    van Breemen MS, Wilms EB, Vecht CJ.
    Lancet Neurol; 2007 May; 6(5):421-30. PubMed ID: 17434097
    [Abstract] [Full Text] [Related]

  • 4. Seizures and Anticonvulsants in Brain Tumours: Frequency, Mechanisms and Anti-Epileptic Management.
    Vecht C, Royer-Perron L, Houillier C, Huberfeld G.
    Curr Pharm Des; 2017 May; 23(42):6464-6487. PubMed ID: 29076421
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Experience of Low Dose Perampanel to Add-on in Glioma Patients with Levetiracetam-uncontrollable Epilepsy.
    Chonan M, Saito R, Kanamori M, Osawa SI, Watanabe M, Suzuki H, Nakasato N, Tominaga T.
    Neurol Med Chir (Tokyo); 2020 Jan 15; 60(1):37-44. PubMed ID: 31748440
    [Abstract] [Full Text] [Related]

  • 7. Seizures in low- and high-grade gliomas: current management and future outlook.
    Vecht CJ, Wilms EB.
    Expert Rev Anticancer Ther; 2010 May 15; 10(5):663-9. PubMed ID: 20469999
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Which treatment strategy in patients with epilepsy with focal seizures uncontrolled by the first anti-seizure medication?
    Zaccara G, Lattanzi S, Brigo F.
    Epilepsy Behav; 2021 Aug 15; 121(Pt A):108031. PubMed ID: 33992932
    [Abstract] [Full Text] [Related]

  • 13. [Newer antiepileptic drugs].
    Matsuura M.
    No To Shinkei; 2007 Feb 15; 59(2):147-56. PubMed ID: 17315756
    [Abstract] [Full Text] [Related]

  • 14. Antiepileptic drug treatment of generalized tonic-clonic seizures: An evaluation of regulatory data and five criteria for drug selection.
    Shorvon SD, Bermejo PE, Gibbs AA, Huberfeld G, Kälviäinen R.
    Epilepsy Behav; 2018 May 15; 82():91-103. PubMed ID: 29602083
    [Abstract] [Full Text] [Related]

  • 15. A survey of antiepileptic drug responses identifies drugs with potential efficacy for seizure control in Wolf-Hirschhorn syndrome.
    Ho KS, Markham LM, Twede H, Lortz A, Olson LM, Sheng X, Weng C, Wassman ER, Newcomb T, Wassman ER, Carey JC, Battaglia A.
    Epilepsy Behav; 2018 Apr 15; 81():55-61. PubMed ID: 29477837
    [Abstract] [Full Text] [Related]

  • 16. Risk factors of paradoxical reactions to anti-seizure medication in genetic generalized epilepsy.
    Gesche J, Hjalgrim H, Rubboli G, Beier CP.
    Epilepsy Res; 2021 Feb 15; 170():106547. PubMed ID: 33421702
    [Abstract] [Full Text] [Related]

  • 17. Antiseizure medication treatment pathways for US Medicare beneficiaries with newly treated epilepsy.
    Terman SW, Youngerman BE, Choi H, Burke JF.
    Epilepsia; 2022 Jun 15; 63(6):1571-1579. PubMed ID: 35294775
    [Abstract] [Full Text] [Related]

  • 18. [Antiepileptic drugs in North America].
    Akiyama T, Otsubo H.
    Brain Nerve; 2010 May 15; 62(5):519-26. PubMed ID: 20450099
    [Abstract] [Full Text] [Related]

  • 19. Optimizing antiepileptic drug treatment in tumoral epilepsy.
    Perucca E.
    Epilepsia; 2013 Dec 15; 54 Suppl 9():97-104. PubMed ID: 24328881
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.